Scarica l'app Stockscreener
2.50
0.40%
0.010
Dopo l'orario di chiusura:
2.48
-0.02
-0.80%
Precedente Chiudi:
$2.49
Aprire:
$2.48
Volume 24 ore:
1.22M
Relative Volume:
0.56
Capitalizzazione di mercato:
$947.63M
Reddito:
$146.59M
Utile/perdita netta:
$-2.93M
Rapporto P/E:
-102.46
EPS:
-0.0244
Flusso di cassa netto:
$-190.40K
1 W Prestazione:
-2.72%
1M Prestazione:
-3.85%
6M Prestazione:
-1.19%
1 anno Prestazione:
+34.41%
Intervallo 1D:
$2.48
$2.54
Intervallo di 1 settimana:
$2.46
$2.5899
Portata 52W:
$1.60
$3.43
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
2.50 | 947.63M | 146.59M | -2.93M | -190.40K | -0.0244 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.77 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.62 | 48.81B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.03 | 44.67B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.57 | 33.27B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
536.12 | 23.50B | 3.18B | 1.33B | 1.04B | 27.90 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Quinn Opportunity Partners LLC Sells 5,965,662 Shares of Cronos Group Inc. $CRON - MarketBeat
Promising Cannabis Stocks To ResearchMarch 13th - MarketBeat
(CRON) Risk-Controlled Trading Report (CRON:CA) - Stock Traders Daily
Promising Cannabis Stocks To Follow NowMarch 11th - MarketBeat
CRON Should I Buy - Intellectia AI
Institution Moves: Is Cronos Group Inc in a long term uptrendPortfolio Return Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Cronos Group (NASDAQ: CRON) officer awarded 63,189 new RSUs in equity grant - Stock Titan
Cronos Group (CRON) officer adds 63,919 RSUs and 21,484 shares - Stock Titan
Cronos Group (CRON) insider gets 904,669 RSUs and exercises 327,801 - Stock Titan
Cronos Group (CRON) officer awarded RSUs and withholds shares for taxes - Stock Titan
(CRON) Trading Performance and Risk Management (CRON:CA) - Stock Traders Daily
Promising Cannabis Stocks To Add to Your WatchlistMarch 9th - MarketBeat
Cannabis Stocks To Watch TodayMarch 8th - MarketBeat
Cronos Group (NASDAQ:CRON) Rating Increased to Hold at Wall Street Zen - MarketBeat
Cronos stock rises after Q1 revenue beat - MSN
Cronos Group (CRON) Q4 2025 earnings, here’s a snapshot - MSN
Cronos Group (CRON) Q4 2025 Earnings, Here’s a Snapshot - Insider Monkey
Cronos Group (CRON) Q4 2025 Earnings, Here's a Snapshot - Finviz
10 Low Risk Penny Stocks to Buy Now - Insider Monkey
Trend Tracker for (CRON) (CRON:CA)Stock Traders Daily Canada - Stock Traders Daily
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Cronos Group Inc. (CRON) Earns Buy Rating and C$4.50 PT on Scalable Model - Finviz
CRON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Promising Cannabis Stocks To Watch TodayMarch 1st - MarketBeat
11 Best Pot Stocks to Buy According to Hedge Funds - Insider Monkey
Best Cannabis Stocks To ConsiderFebruary 28th - MarketBeat
How The Cronos Group (TSX:CRON) Story Is Shifting With New Targets And Execution Risks - Yahoo Finance
Cronos Group (NASDAQ:CRON) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Cronos Group Inc. (NASDAQ:CRON) Q4 2025 Earnings Call Transcript - Insider Monkey
Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight - GuruFocus
Cronos Group (NASDAQ:CRON) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Cronos Group (CRON) officer Jared Kenost reports RSU and share holdings - Stock Titan
Cronos Group Inc. stock falls Thursday, underperforms market - MarketWatch
Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus
Cronos Group Q4 Earnings Call Highlights - MarketBeat
Cronos Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Call Summary | Cronos Group Inc(CRON.CA) Q4 2025 Earnings Conference - 富途牛牛
Cronos Group sees record revenue in 2025 amidst international expansion - StratCann
Cronos Group Posts Record 2025 Revenue and Eyes European Cannabis Expansion - TipRanks
Earnings call transcript: Cronos Group Q4 2025 sees revenue miss, stock down - Investing.com
Cronos Group Shares Fall After Posting Swing to Q4 Loss, Net Revenue Gain - marketscreener.com
Cronos Group Swings to Q4 Loss - marketscreener.com
Earnings Flash (CRON) Cronos Posts Q4 Net Revenue $44.5M - marketscreener.com
Earnings Flash (CRON) Cronos Group Inc. Reports Q4 Revenue $44.5M, vs. FactSet Est of $38.7M - marketscreener.com
Cronos stock down as company swings to Q4 loss (CRON:NASDAQ) - Seeking Alpha
Cronos: Q4 Earnings Snapshot - marketscreener.com
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results - The Manila Times
Cronos Group Inc. SEC 10-K Report - TradingView
Cronos Group Earnings Review: Q4 Summary - Benzinga
Cronos Group Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Cronos Group Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.15%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):